These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34378540)

  • 1. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
    Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
    Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Evaluation of a Novel Teoptinib Derivative as an Effective Anti-hepatocellular Carcinoma Agent.
    Yu H; Zhang X; Li J; Wang K; Yin C; Li X; Li L; Shao G; Jin S
    Curr Pharm Des; 2024; 30(27):2167-2178. PubMed ID: 38919077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.
    Liang Z; Lei F; Deng J; Zhang H; Wang Y; Li J; Shi T; Yang X; Wang Z
    Eur J Med Chem; 2022 Jan; 228():113960. PubMed ID: 34774339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
    Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
    Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
    Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
    Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
    Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Evodiamine-Glucose Conjugates with Improved
    Wu Z; Chen S; Chen Z; Dong G; Xu D; Sheng C
    J Med Chem; 2024 May; 67(9):7373-7384. PubMed ID: 38646851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway.
    Hu CY; Wu HT; Su YC; Lin CH; Chang CJ; Wu CL
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28708106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation.
    Hawash M; Kahraman DC; Cetin-Atalay R; Baytas SN
    Chem Biodivers; 2021 May; 18(5):e2001037. PubMed ID: 33713038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
    Guo XX; Li XP; Zhou P; Li DY; Lyu XT; Chen Y; Lyu YW; Tian K; Yuan DZ; Ran JH; Chen DL; Jiang R; Li J
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30384473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
    Li P; Liu Y; He Q
    Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo.
    Yu XQ; Yan QL; Shen S; Cheng ZY; Huang XX; Yao GD; Song SJ
    Bioorg Chem; 2022 Feb; 119():105509. PubMed ID: 34844768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
    Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
    Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytotoxic and mechanistic effects of aaptamine on hepatocellular carcinoma.
    Li QL; Zhang PP; Wang PQ; Yu HB; Sun F; Hu WZ; Wu WH; Zhang X; Chen F; Chu ZY; Zhang JP; Chen SS; Lin HW
    Anticancer Agents Med Chem; 2015; 15(3):291-7. PubMed ID: 25403168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents.
    Lei F; Xiong Y; Wang Y; Zhang H; Liang Z; Li J; Feng Y; Hao X; Wang Z
    J Med Chem; 2022 Jun; 65(11):7975-7992. PubMed ID: 35639640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma.
    Yang F; Shi L; Liang T; Ji L; Zhang G; Shen Y; Zhu F; Xu L
    Biochem Biophys Res Commun; 2017 Mar; 485(1):54-61. PubMed ID: 28189683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia.
    Li YL; Zhang NY; Hu X; Chen JL; Rao MJ; Wu LW; Li QY; Zhang B; Yan W; Zhang C
    Biochem Biophys Res Commun; 2018 Apr; 498(3):481-486. PubMed ID: 29505792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
    Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
    Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.